Medtronic Plc risk profile
41 Elevated one input has moved against it
Measured 21 October 2026 from MDT's filed statements. Recomputed nightly.
41 (Elevated), driven by Competitive position at 56, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 24 | Normal | Stable | One-year price volatility — 24.7% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 23 | Normal | Stable | Capital spending against operating cash — 0.26x |
| Leverage and coverage | 28 | Normal | Worsening | Net debt to EBITDA — 2.65x |
| Competitive position | 56 | Elevated | Stable | Operating-margin gap against peers — -0.7 percentage points |
| Concentration | 37 | Normal | Stable | Geographic concentration — 2,459 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.